Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the effects of CLP on serum potassium and signs and symptoms of fluid overload in heart failure patients with chronic kidney disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sorbent Therapeutics
Collaborators
NCT06222762 · Heart Failure
NCT06052475 · Pacing-Induced Cardiomyopathy, Heart Failure
NCT06675552 · Heart Disease, Heart Failure, and more
NCT05666518 · Chronic Heart Failure
NCT05677100 · Heart Failure, Cardiorenal Syndrome, and more
Yerevan
Tbilisi
Chisinau
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions